Dan Hu

1.7k citations
77 papers · 1.2k indexed · h-index 22
Topics
Cancer Immunotherapy and Biomarkers (6 papers)Head and Neck Cancer Studies (5 papers)Gastric Cancer Management and Outcomes (4 papers)

In The Last Decade

Dan Hu

72 papers receiving 1.2k citations

Peers

Dan Hu
Comparison fields: 5 of 122
  • Oncology 273
  • Molecular Biology 217
  • Pulmonary and Respiratory Medicine 203
  • Cancer Research 179
  • Public Health, Environmental and Occupational Health 163
Replace Chunfang Zhu with:
Chunfang Zhu China
Jing Tian China
Xiaoyan Wu China
Angela Criscimanna Italy
Jerrold Grodin United States
Charbel Abi Khalil Qatar
V. Kerlan France
E. E. Calle United States
Mahdi Sheikh Iran
Carine Biessy France
Dan Hu relative to Chunfang Zhu China Chunfang Zhu's profile →
Citations per field
00.5×1.5×
Chunfang Zhu · 1×
Citations per year

Countries citing papers authored by Dan Hu

Since Specialization
Citations

This map shows the geographic impact of Dan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Hu more than expected).

Fields of papers citing papers by Dan Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Hu. The network helps show where Dan Hu may publish in the future.

Co-authorship network of co-authors of Dan Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Hu. A scholar is included among the top collaborators of Dan Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Hu. Dan Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 1
5 2
6 4
7 11
8 27
9 3
10
Abstract 12335: Acacetin, a Potent Transient Outward Current Blocker, May Serve as a Novel Therapeutic for KCND3-encoded Kv4.3 Gain-of-function-associated Brugada Syndrome
1
11 21
12 14
13 6
14 36
15 9
16 46
17 29
18 41
19 95
20 2

About Dan Hu

Dan Hu is a scholar working on Otorhinolaryngology, Oncology and Cancer Research, having authored 77 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Head and Neck Cancer Studies (5 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Reproductive Medicine (147 citations), Obstetrics and Gynecology (101 citations) and Cancer Research (179 citations). Dan Hu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Xiandong Lin, Bo Huang, Guijin Zhu, Weifeng Zhu, Feng Peng, Kun Qian, Hanwang Zhang, Kan Jiang, Jihui Ai and Yufeng Li. Their work appears in journals such as The Lancet, Circulation and Journal of Hazardous Materials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026